Bio-Medical Applications Of Alabama, Inc. is a medicare approved dialysis facility center in Anniston, Alabama and it has 10 dialysis stations. It is located in Calhoun county at 2017 Quintard Ave, Suite B, Anniston, AL, 36201. You can reach out to the office of Bio-Medical Applications Of Alabama, Inc. at (256) 235-2452. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Alabama, Inc. has the following ownership type - Profit. It was first certified by medicare in December, 2015. The medicare id for this facility is 012682 and it accepts patients under medicare ESRD program.
| Name | Bio-Medical Applications Of Alabama, Inc. |
|---|---|
| Location | 2017 Quintard Ave, Suite B, Anniston, Alabama |
| No. of Dialysis Stations | 10 |
| Medicare ID | 012682 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2017 Quintard Ave, Suite B, Anniston, Alabama, 36201 | |
| (256) 235-2452 | |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
| NPI Number | 1679951974 |
| Organization Name | Fresenius Medical Care Anniston North |
| Doing Business As | Bio-medical Applications Of Alabama, Inc. |
| Address | 2017 Quintard Ave Anniston, Alabama, 36201 |
| Phone Number | (256) 235-2925 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 11 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 9 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 23 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 229 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Alabama, Inc. with elevated calcium levels.
| Patients with hypercalcemia | 23 |
| Hypercalcemia patient months | 229 |
| Patients with Serumphosphor | 23 |
| Patients with Serumphosphor less than 3.5 mg/dL | 13 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 24 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 20 |
| Patient months included in arterial venous fistula and catheter summaries | 170 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 49 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 2 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 17 |
| Hospitalization Rate in facility | 269.6 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 669 |
| Hospitalization Rate: Lower Confidence Limit | 116.7 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Alabama, Inc. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 15 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 33.5 |
| Readmission Rate: Lower Confidence Limit | 4.5 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Bio-Medical Applications Of Alabama, Inc.'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 16 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Bio-Medical Applications Of Alabama, Inc. lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 23 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago
RAI East 11th St Anniston Location: 522 East 11th Street, Anniston, Alabama, 36207 Phone: (256) 237-7566 |
Bio-Medical Applications Of Alabama, Inc. Location: 2017 Quintard Ave, Suite B, Anniston, Alabama, 36201 Phone: (256) 235-2452 |
Fresenius Medical Care Anniston Home, Llc Location: 2017 Quintard Avenue, Suite A, Anniston, Alabama, 36201 Phone: (256) 237-7340 |
News Archive
The standard approach, which is based on age alone, has been challenged in recent years by a number of health experts who contend that some women get more mammograms than they need and others get too few.
The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance. In findings reported in Molecular Cancer, Fengzhi Li, PhD, of Roswell Park Cancer Institute, and colleagues provide new evidence that FL118 may be more effective than two structurally similar injectable drugs and, additionally, may be effective as an oral agent.
The impact of combat injury on intimacy is an important and often neglected aspect of healthcare communication. Four new fact sheets addressing the impact of the injuries of war, both physical and psychological, on intimacy have just been released for healthcare providers and affected military families.
The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme that recurs or progresses after receiving chemotherapy and radiation therapy.
Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?
› Verified 6 days ago